It appears that the exchange of genetic information is of crucial importance. The prospective genetic market must ensure protection from possible misuse and genetic discrimination in particular. It is particularly important to maintain transparency and equal access to this market.
Zenome aims at creating the personal genomics infrastructure, that would enable participants to:
The principal customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.
Inside Zenome Platform different types of information are inextricably intertwined. The nature of each type determines the way to store information of that kind.
Treating data of different kind differently provides privacy as well as scalability of the system.
Since all data transactions, including buying and selling data, are governed by smart-contracts, interactions can only include balances stored on blockchains.
Using any of pre-existing tokens for this purpose would result in unreasonable dependence on the valuation of external token. Thus, a separate utility token should be issued to power economic interactions on the platform.